Recommendations for vaccination in patients with multiple sclerosis who are eligible for immunosuppressive therapies: Spanish consensus statement-Reference-Cited by-同舟云学术

Recommendations for vaccination in patients with multiple sclerosis who are eligible for immunosuppressive therapies: Spanish consensus statement

Published:2021-01 Issue:1 Volume:36 Page:50-60
ISSN:2173-5808
Container-title:Neurología (English Edition)
language:en
Short-container-title:Neurología (English Edition)

Author:

Otero-Romero S.,Rodríguez-García J.,Vilella A.,Ara J.R.,Brieva L.,Calles C.,Carmona O.,Casanova V.,Costa-Frossard L.,Eichau S.,García-Merino J.A.,Garcia-Vidal C.,González-Platas M.,Llaneza M.,Martínez-Ginés M.,Meca-Lallana J.E.,Prieto J.M.,Rodríguez-Antigüedad A.,Tintoré M.,Blanco Y.,Moral E.

Publisher

Elsevier BV

Subject

General Materials Science

Reference68 articles.

1. Multiple sclerosis;Thompson;Lancet (London, England).,2018

2. Treatment decisions in multiple sclerosis - insights from real-world observational studies;Trojano;Nat Rev Neurol.,2017

3. Comparison of efficacy and safety of oral agents for the treatment of relapsing-remitting multiple sclerosis;Guarnera;Drug Des Dev Ther.,2017

4. Monoclonal antibodies for relapsing multiple sclerosis: a review of recently marketed and late-stage agents;Blinkenberg;CNS Drugs.,2017

5. Managing risks with immune therapies in multiple sclerosis;Forster;Drug Saf.,2019

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Managing multiple sclerosis in individuals aged 55 and above: a comprehensive review;Frontiers in Immunology;2024-04-05

2. Prolonged observation after the use of cladribine in multiple sclerosis: efficacy and safety;Neurology, Neuropsychiatry, Psychosomatics;2023-08-21